Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome.
Ontology highlight
ABSTRACT: Trisomy of human chromosome 21 (Down syndrome, DS) alters development of multiple organ systems, including the face and underlying skeleton. Besides causing stigmata, these facial dysmorphologies can impair vital functions such as hearing, breathing, mastication, and health. To investigate the therapeutic potential of green tea extracts containing epigallocatechin-3-gallate (GTE-EGCG) for alleviating facial dysmorphologies associated with DS, we performed an experimental study with continued pre- and postnatal treatment with two doses of GTE-EGCG supplementation in a mouse model of DS, and an observational study of children with DS whose parents administered EGCG as a green tea supplement. We evaluated the effect of high (100 mg/kg/day) or low doses (30 mg/kg/day) of GTE-EGCG, administered
SUBMITTER: Starbuck JM
PROVIDER: S-EPMC7907288 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA